⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CNTX News
Context Therapeutics Inc. Common Stock
Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer
globenewswire.com
CNTX
Form 8-K
sec.gov
CNTX
Context Therapeutics Reports Full Year 2025 Operating and Financial Results
globenewswire.com
CNTX
Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026
globenewswire.com
CNTX
Form 8-K
sec.gov
CNTX
Form 8-K
sec.gov
CNTX
Context Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
CNTX
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
CNTX
Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards
globenewswire.com
ONCY
IMNM
PRLD
CNTX
RLAY
Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting
globenewswire.com
CNTX